Sigma-Aldrich Corporation (NASDAQ:SIAL), a leading Life Science and High Technology company, announced it has completed its acquisition of BioReliance Holdings, Inc., a leading provider of global biopharmaceutical testing services, from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments. Read more...

Read more here: http://www.sacbee.com/2012/01/31/4228849/sigma-aldrich-completes-acquisition.html#storylink=cpy

Sigma-Aldrich Completes Acquisition of BioReliance - PR Newswire - sacbee.com